HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

QLT 0267

inhibits both FMS-like tyrosine kinase 3 (FLT3) and integrin linked kinase (ILK); structure in first source
Also Known As:
QLT-0267; QLT0267
Networked: 14 relevant articles (3 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bally, Marcel B: 4 articles (01/2015 - 01/2006)
2. Kalra, Jessica: 4 articles (01/2015 - 01/2008)
3. Dedhar, Shoukat: 4 articles (01/2009 - 01/2006)
4. Mills, Gordon B: 3 articles (01/2007 - 08/2005)
5. Warburton, Corinna: 2 articles (05/2011 - 01/2009)
6. Waterhouse, Dawn: 2 articles (05/2011 - 01/2009)
7. Yan, Hong: 2 articles (05/2011 - 01/2008)
8. Daynard, Tim: 2 articles (01/2009 - 01/2008)
9. Dunn, Sandra E: 2 articles (01/2007 - 01/2006)
10. Jasser, Samar A: 2 articles (01/2007 - 08/2005)

Related Diseases

1. Neoplasms (Cancer)
2. Squamous Cell Carcinoma of Head and Neck
3. Breast Neoplasms (Breast Cancer)
4. Sarcoma (Soft Tissue Sarcoma)
5. Glioblastoma (Glioblastoma Multiforme)

Related Drugs and Biologics

1. integrin-linked kinase
2. Docetaxel (Taxotere)
3. Actins (F Actin)
4. TOR Serine-Threonine Kinases
5. Phosphotransferases (Kinase)
6. Caspase 3 (Caspase-3)
7. Apoptosis Regulatory Proteins
8. Therapeutic Uses
9. Glycogen Synthase Kinase 3
10. Integrins

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)